MACROGOLS

Colonic Neoplasms

Zhang Xiaofeng,MDmixtureN/AActive

D

30/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 81/ 100

Competitive context

13 Active assets in the Colonic Neoplasms cohort.

Asset / Sponsor	Phase	Rating
Eloxatin First Affiliated Hospital of Guangxi Medical University	Phase 4	BBB
PROPOFOL Hillel Yaffe Medical Center	Phase 4	BB
Ertapenem University of Ulm	Phase 4	BB
Levoleucovorin Asan Medical Center	Phase 2	BB
Sevoflurane Uppsala University	Phase 4	BB

View all 50 →

Same molecule, other indications

MACROGOLS is also rated in:

inflammatory bowel diseaseDormant

A

Indicative ·

81 / 100

polyp of colonDormant

BBB

Indicative ·

75 / 100

Surgical Site InfectionDormant

BBB

Indicative ·

72 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.